Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 21121-21130 Newer>

The Motley Fool February 28, 2007	TXU Goes Lights Out: Fool by Numbers The electricity generation company released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool February 28, 2007 Brian Lawler	Time to Buy Shares of Adolor? Drug developer Adolor announces its fourth-quarter financial results as investors await pivotal clinical trial results.
The Motley Fool February 28, 2007 Anders Bylund	Finding True Value: Relative Valuation Don't invest a dime before you figure out what that company really is worth.
The Motley Fool February 28, 2007 Matt Koppenheffer	The 5-Sigma Report A look at the stocks that saw serious volatility last week. Florida Rock... NovaStar Financial... Chemed... Verigy... Whole Foods Market...
The Motley Fool February 28, 2007 Tim Beyers	Fool on the Street: Chilling With Coke Let's hope they like sugar water in Japan. If so, Coke investors could reap big rewards in the long term.
The Motley Fool February 28, 2007	Federated Deparment Stores Rings In: Fool by Numbers The department store retailer released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool February 28, 2007 David Lee Smith	Florida Flags Hovnanian The homebuilder takes $90 million in charges in the Sunshine State. The housing market continues to exhibit softness nationwide, with some areas clearly being harder hit than others. Investors, take note.
The Motley Fool February 28, 2007 Brian Lawler	Merck's Mighty Future Merck ups its 2007 financial forecast, while positive developments occur for two of its most promising new therapies.
The Motley Fool February 28, 2007 Anders Bylund	Hansen's Wild Ride Hang on to your hats, Hansen investors. It's gonna be a full-speed ride on a bumpy track.
The Motley Fool February 28, 2007 Matt Koppenheffer	P&G to Help Syneron Smooth Its Customers The consumer-goods giant teams up with the small cap to treat consumers' skin. The real question for investors, though, is how these new products will impact the company's financials.
<Older 21121-21130 Newer> Return to current articles.